TELA

TELA

USD

TELA Bio Inc. Common Stock

$1.870-0.050 (-2.604%)

Real-time Price

Healthcare
Medical devices
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.920

High

$2.050

Low

$1.860

Volume

0.07M

Company Fundamentals

Market Cap

74.0M

Industry

Medical devices

Country

United States

Trading Stats

Avg Volume

0.27M

Exchange

NGM

Currency

USD

52-Week Range

Low $0.865Current $1.870High $5.6

Related News

GlobeNewswire

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that

View more
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the

View more
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
GlobeNewswire

TELA Bio Appoints Jeffrey Blizard as President

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the

View more
TELA Bio Appoints Jeffrey Blizard as President
GlobeNewswire

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the

View more
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference